The current ATXS market cap is 751.62M. The company's latest EPS is USD -0.9441 and P/E is -9.05.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -12.39M | -14.29M | -13.49M | -15.1M | -20.24M |
Net Income | -12M | -13.26M | -11.19M | -12.57M | -17.73M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -26.37M | -27.09M | -37.44M | -194.98M | -53.5M |
Net Income | -25.87M | -26.29M | -37.3M | -194.91M | -51.83M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 119.82M | 230.63M | 218.24M | 207.05M | 193.86M |
Total Liabilities | 6.95M | 9.42M | 6.88M | 6.65M | 9.38M |
Total Equity | 112.87M | 221.22M | 211.36M | 200.4M | 184.48M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 39.17M | 41.78M | 47.46M | 127.51M | 230.63M |
Total Liabilities | 4.23M | 6.06M | 6.79M | 5.2M | 9.42M |
Total Equity | 34.94M | 35.72M | 40.67M | 122.31M | 221.22M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -32.87M | -43.53M | -13.25M | -23.95M | -38.21M |
Investing | -31.95M | -167.13M | 194.99M | 137.07M | 137.07M |
Financing | 24.32M | 144.72M | 37k | 310k | 420k |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -23.47M | -26.57M | -32.49M | -30.15M | -43.53M |
Investing | -21.91M | -4.08M | 6.3M | -12.56M | -167.13M |
Financing | 44.3M | 25.62M | 40.86M | 104.28M | 144.72M |
Market Cap | 751.62M |
Price to Earnings Ratio | -9.05 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 22.85 |
Price to Book Ratio | 2.12 |
Dividend Yield | - |
Shares Outstanding | 54.9M |
Average Volume (1 week) | 1.96M |
Average Volume (1 Month) | 1.5M |
52 Week Change | 13.89% |
52 Week High | 16.90 |
52 Week Low | 4.26 |
Spread (Intraday) | 1.2 (8.12%) |
Company Name | Astria Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.astriatx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.